 LA JOLLA, Calif.--BUSINESS WIRE--DermTech, Inc. NASDAQ: DMTK DermTech or the Company, a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that its chief medical officer, Dr. Loren Clarke, will present study data illustrating how genomic technology can enhance melanoma detection and improve patient care at Americas Health Insurance Plans AHIP 2022. The meeting is being held from June 21-23, 2022 in Las Vegas, Nev. Across the spectrum 